サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1567804

欧州のニキビ治療薬市場：2030年までの市場予測 - 地域分析 - 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別

Europe Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

出版日
ページ情報
英文 127 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州のニキビ治療薬市場：2030年までの市場予測 - 地域分析 - 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別
出版日: 2024年08月07日
発行: The Insight Partners
ページ情報: 英文 127 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のニキビ治療薬市場は、2022年に19億6,308万米ドルと評価され、2030年には31億1,269万米ドルに達すると予測され、2023年から2030年までのCAGRは6.0%と推定されます。

最先端技術とデータ主導戦略に基づく個別化治療プログラムが欧州のニキビ治療薬市場を牽引

欧州のニキビ治療薬市場では、先端技術とデータ駆動型アプローチを採用することで、研究開発の新たな道が開かれます。患者データを収集・分析することで、研究者はニキビの根本的原因に関する貴重な洞察を得ることができ、治療反応のパターンと動向を特定し、治療介入のための新たな潜在的標的を発見することができます。これにより、新規薬剤や革新的な治療戦略、ニキビ患者の多様なニーズに合わせたよりパーソナライズされたスキンケア製品の開発を推進することができます。人工知能（AI）、機械学習アルゴリズム、遺伝子検査、その他の最先端ツールを活用することで、ヘルスケアプロバイダーは膨大なデータを分析し、患者固有の皮膚状態、遺伝的素因、ライフスタイル要因、治療反応をより深く理解できるようになった。このような個別化アプローチにより、患者一人ひとりのニーズに対応するよう特別に設計された、オーダーメイドの治療計画を策定することが可能になります。

2021年3月、Thorne HealthTechの子会社でヘルスインテリジェンス企業であるOnegevity社は、美容・パーソナルケア製品の世界的トップメーカーの1つであるユニリーバと提携し、ニキビの介入と治療に対するより個別化されたアプローチを可能にしました。この科学的共同研究は、マルチオミクス（異なる生物学的分野の統合）の可能性を調査し、ニキビ治療への個別化アプローチを可能にすることを目的としています。この共同研究は、人の健康に影響を与える何十億もの生物学的特性の評価を可能にするOnegevityのAIと機械学習機能を活用することで、カスタマイズされたニキビ治療計画を可能にする新たな診断モデルを生み出すことを目的としています。パーソナライズされた治療計画は、患者特有の特性やニキビ治療薬への反応に影響を及ぼす可能性のある要因を考慮することで、治療効果を最適化するのに役立ちます。このような患者固有のデータに基づいて、ヘルスケアプロバイダーは、その特定の個人にとってより効果的である可能性の高い治療を処方することができます。これにより、ニキビの治療が成功する可能性が向上し、副作用や有害反応の可能性が減少するため、患者の転帰が改善し、満足度が向上します。このように、パーソナライズされた治療計画を設計するための先進技術とデータ主導型アプローチの統合は、欧州のニキビ治療薬市場における技術革新、成長、患者の転帰改善のための大きな機会を生み出しています。

欧州のニキビ治療薬市場概要

欧州は世界のニキビ治療薬市場で第2位にランクされています。さらに、予測期間中に大きなCAGRを記録すると予測されています。同地域におけるニキビ治療薬市場の成長は、ニキビの有病率の増加と主要企業の存在感の高まりに起因しています。研究ベースの製薬業界は、欧州のニキビ治療薬市場の成長を支え、世界経済における将来の競争力を確保する上で重要な役割を果たすことができます。皮膚科遠隔医療のパイオニアであるベルリンのフォーメル・スキン社は、2022年1月に3,235万（3,000万）米ドルのシリーズ資金調達ラウンドを完了したと発表しました。この資金調達はSingularとHeal Capitalが主導し、Cherry Ventures、Heartcore Capital、Vorwerk Venturesが支援しました。今回の資金調達により、同社は遠隔スキンケアプラットフォームの長期的な開発と拡大を計画しています。

欧州のニキビ治療薬市場の収益と2030年までの予測（金額）

欧州のニキビ治療薬市場のセグメンテーション

欧州のニキビ治療薬市場は、治療クラス、製剤、タイプ、ニキビタイプ、流通チャネル、国に基づいてセグメント化されます。

治療クラス別では、欧州のニキビ治療薬市場はレチノイド、過酸化ベンゾイル、抗生物質、サリチル酸、その他に区分されます。2022年にはレチノイドセグメントが最大のシェアを占めています。

剤型別では、欧州のニキビ治療薬市場は外用薬と内服薬に二分されます。外用薬セグメントは2022年に最大のシェアを占めました。

タイプ別では、欧州のニキビ治療薬市場は処方薬と市販薬に二分されます。2022年には、処方薬セグメントがより大きな最大シェアを占めました。

ニキビタイプ別に見ると、欧州のニキビ治療薬市場は非炎症性ニキビと炎症性ニキビに二分されます。2022年には炎症性ニキビ分野がより大きなシェアを占めています。

販売チャネル別では、欧州のニキビ治療薬市場は薬局・薬店、小売店、eコマースに区分されます。薬局・薬店セグメントが2022年に最大のシェアを占めました。

国別では、欧州のニキビ治療薬市場はドイツ、フランス、英国、イタリア、スペイン、その他欧州に分類されます。2022年の欧州のニキビ治療薬市場はドイツが支配的でした。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、Johnson &Johnson、Bausch Health Companies Inc、Galderma SA、Pfizer Inc、GSK Plc、Viatris Inc、Pierre Fabre SAは、欧州のニキビ治療薬市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のニキビ治療薬市場情勢

  • PEST分析
  • 外用薬と経口薬の価格分析
  • ニキビ治療を受ける患者層

第5章 欧州のニキビ治療薬市場：主要市場力学

  • 欧州のニキビ治療薬市場- 主要市場力学
  • 主要市場促進要因
    • 重症ニキビの有病率の増加
    • 新薬の発売
  • 主な市場抑制要因
    • ニキビ治療薬に伴う副作用
  • 主な市場機会
    • 最先端技術とデータ主導型戦略に基づく個別化治療プログラム
  • 今後の動向
    • オーガニック・ナチュラル治療へのニーズの高まり
  • 促進要因と抑制要因の影響

第6章 ニキビ治療薬市場- 欧州市場分析

第7章 欧州のニキビ治療薬市場分析-治療クラス別

  • レチノイド
  • 過酸化ベンゾイル
  • 抗生物質
  • サリチル酸
  • その他

第8章 欧州のニキビ治療薬市場分析：剤形別

  • 外用薬
  • 経口薬

第9章 欧州のニキビ治療薬市場分析：タイプ別

  • 処方薬
  • 市販薬

第10章 欧州のニキビ治療薬市場分析：ニキビタイプ別

  • 非炎症性ニキビ
  • 炎症性ニキビ

第11章 欧州のニキビ治療薬市場分析：流通チャネル別

  • 薬局・ドラッグストア
  • 小売店
  • eコマース

第12章 欧州のニキビ治療薬市場：国別

  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州

第13章 ニキビ治療薬市場：業界情勢

  • ニキビ治療薬市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
  • ファルマピエルと他社ニキビ治療薬の製品比較

第14章 企業プロファイル

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Pierre Fabre SA

第15章 付録

図表

List Of Tables

  • Table 1. Europe Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 27. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 28. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 30. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 31. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 32. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 33. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 35. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 36. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 37. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 38. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 39. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 40. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 41. Recent Organic Growth Strategies in Acne Medication Market
  • Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. Europe Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Acne Medication Market Revenue (US$ Million), 2022-2030
  • Figure 5. Europe Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 6. Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 12. Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 15. Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Europe Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 18. Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 26. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Growth Strategies in Acne Medication Market
目次
Product Code: BMIRE00030657

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market

Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview

Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Europe Acne Medication Market Segmentation

The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. Europe Acne Medication Market - Key Market Dynamics

  • 5.1 Europe Acne Medication Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Increasing Prevalence of Severe Acne
    • 5.2.2 Launch of Novel Drugs
  • 5.3 Key Market Restraints
    • 5.3.1 Side Effects Associated with Acne Medication
  • 5.4 Key Market Opportunities
    • 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.5 Future Trends
    • 5.5.1 Upsurge in Need for Organic and Natural Treatments
  • 5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Europe Market Analysis

7. Europe Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Europe Acne Medication Market - Country Analysis

  • 12.1 Europe
    • 12.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 Germany
      • 12.1.1.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 France
      • 12.1.1.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 France: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 UK
      • 12.1.1.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.8 Italy
      • 12.1.1.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type
        • 12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.10 Spain
      • 12.1.1.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type
        • 12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.12 Rest of Europe
      • 12.1.1.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
        • 12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Almirall SA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson & Johnson
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sun Pharmaceutical Industries Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Bausch Health Companies Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Galderma SA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Pfizer Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 GSK Plc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Viatris Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Pierre Fabre SA
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms